126 related articles for article (PubMed ID: 24366121)
1. Neuroendocrine cancer: Insulinomas-recurrent mutations identified in YY1.
Greenhill C
Nat Rev Endocrinol; 2014 Mar; 10(3):127. PubMed ID: 24366121
[No Abstract] [Full Text] [Related]
2. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.
Cao Y; Gao Z; Li L; Jiang X; Shan A; Cai J; Peng Y; Li Y; Jiang X; Huang X; Wang J; Wei Q; Qin G; Zhao J; Jin X; Liu L; Li Y; Wang W; Wang J; Ning G
Nat Commun; 2013; 4():2810. PubMed ID: 24326773
[TBL] [Abstract][Full Text] [Related]
3. Frequency and consequence of the recurrent
Parekh VI; Modali SD; Welch J; Simonds WF; Weinstein LS; Kebebew E; Agarwal SK
Endocr Relat Cancer; 2018 May; 25(5):L31-L35. PubMed ID: 29467239
[No Abstract] [Full Text] [Related]
4. [Expression of YY 1 protein in human insulinoma and its clinical implication].
Li WX; Huang YE; Shi XX; Lin PX; Zhou ZN; Zhang YZ; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):361-4. PubMed ID: 27063163
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.
Lichtenauer UD; Di Dalmazi G; Slater EP; Wieland T; Kuebart A; Schmittfull A; Schwarzmayr T; Diener S; Wiese D; Thasler WE; Reincke M; Meitinger T; Schott M; Fassnacht M; Bartsch DK; Strom TM; Beuschlein F
J Clin Endocrinol Metab; 2015 May; 100(5):E776-82. PubMed ID: 25763608
[TBL] [Abstract][Full Text] [Related]
6. Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.
Cromer MK; Choi M; Nelson-Williams C; Fonseca AL; Kunstman JW; Korah RM; Overton JD; Mane S; Kenney B; Malchoff CD; Stalberg P; Akerström G; Westin G; Hellman P; Carling T; Björklund P; Lifton RP
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4062-7. PubMed ID: 25787250
[TBL] [Abstract][Full Text] [Related]
7. Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance.
Song YL; Xu J; Zhao DC; Zhang TP; Jin KZ; Zhu LM; Yu S; Chen YJ
Endocr Pract; 2021 Sep; 27(9):874-880. PubMed ID: 33705973
[TBL] [Abstract][Full Text] [Related]
8. Mutation Status in Yin Yang 1 Gene in X-ray-Induced Insulinoma Cell Line Rin-5F.
Kiba T
Pancreas; 2020 Jul; 49(6):e49-e50. PubMed ID: 32590621
[No Abstract] [Full Text] [Related]
9. T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients.
Irshad K; Jyotsna VP; Agarwal S; Chosdol K; Pal S; Deepak RK
Horm Metab Res; 2017 Jun; 49(6):452-456. PubMed ID: 28472826
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
Hong X; Qiao S; Li F; Wang W; Jiang R; Wu H; Chen H; Liu L; Peng J; Wang J; Jia C; Liang X; Dai H; Jiang J; Zhang T; Liao Q; Dai M; Cong L; Han X; Guo D; Liang Z; Li D; Zheng Z; Ye C; Li S; Zhao Y; Wu K; Wu W
Gut; 2020 May; 69(5):877-887. PubMed ID: 31462556
[TBL] [Abstract][Full Text] [Related]
11. Aggressive versus indolent insulinomas: new clinicopathological insights.
Hackeng WM; Brosens LAA; Dreijerink KMA
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
[TBL] [Abstract][Full Text] [Related]
12. Significance of the pathogenic mutation T372R in the Yin Yang 1 protein interaction with DNA--thermodynamic studies.
Nieborak A; Górecki A
FEBS Lett; 2016 Mar; 590(6):838-47. PubMed ID: 26910132
[TBL] [Abstract][Full Text] [Related]
13. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
14. Increased EpCAM expression in malignant insulinoma: potential clinical implications.
Raffel A; Eisenberger CF; Cupisti K; Schott M; Baldus SE; Hoffmann I; Aydin F; Knoefel WT; Stoecklein NH
Eur J Endocrinol; 2010 Feb; 162(2):391-8. PubMed ID: 20097833
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang-1 increases apoptosis through Bax activation in pancreatic cancer cells.
Zhang JJ; Zhu Y; Yang C; Liu X; Peng YP; Jiang KR; Miao Y; Xu ZK
Oncotarget; 2016 May; 7(19):28498-509. PubMed ID: 27074573
[TBL] [Abstract][Full Text] [Related]
16. Novel gene activated in rat insulinomas.
Takasawa S; Yamamoto H; Terazono K; Okamoto H
Diabetes; 1986 Oct; 35(10):1178-80. PubMed ID: 3019805
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of p16(INK4a) alterations in insulinomas.
Bartsch DK; Kersting M; Wild A; Ramaswamy A; Gerdes B; Schuermann M; Simon B; Rothmund M
Digestion; 2000; 62(2-3):171-7. PubMed ID: 11025365
[TBL] [Abstract][Full Text] [Related]
18. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
20. Absence of mutations in the Gs alpha and Gi2 alpha genes in sporadic parathyroid adenomas and insulinomas.
Vessey SJ; Jones PM; Wallis SC; Schofield J; Bloom SR
Clin Sci (Lond); 1994 Nov; 87(5):493-7. PubMed ID: 7874835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
